Teva

Sanofi and Teva Collaborate on Inflammatory Bowel Disease Treatment, TEV’574, in $1.5 Billion Deal

(IN BRIEF) Sanofi and Teva Pharmaceuticals have announced a collaboration to co-develop and co-commercialize TEV’574, a promising asset currently in…

7 months ago

CVC Capital Partners: Anish Mehta appointed CEO of the international women’s health assets portfolio acquired from Teva

LUXEMBOURG, 11-Oct-2017 — /EuropaWire/ — CVC Capital Partners (“CVC”) today announced that former Allergan executive Anish Mehta will be appointed as…

7 years ago